FindTrial
Sign In

Comparing two treatments for second-degree internal haemorrhoids: Karanj Pratisaraniya Kshara and sclerotherapy.

A comparative clinical effect of Karanj Pratisaraniya Kshara application and sclerotherapy in the management of Arsha, with special reference to second-degree internal haemorrhoids: An open-label randomized clinical study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075122
Enrollment
40
Registered
2024-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

None listed

Sponsors

Shree Swaminarayan Ayurvedic College,Kalol
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged- 18 years to 60 years will be included in this study. 2. Patients who are suffering from Primary Haemorrhoids will be included. 3. Mridu, Prastruta, Avagadha, and Uchritani soft, deep-seated, and elevated Haemorrhoid)types of Arsha will be included.8 4. Patients who are indicated for pratisarana khara karma. (Su. Su.11/7)

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years and more than 60 years will be excluded. 2. Patients other than primary Haemorrhoids will be excluded. 3. Patients having Acute Bleeding with Haemorrhoid will be excluded. 4. Patients having rectal prolapse will be excluded. 5. Haemorrhoids associated with fissure and Fistula-in-ano will be excluded. 6. Patient having uncontrolled HTN Systolic more than 150mm/Hg, Diastolic BP more than 90 mm/Hg, DM RBS More than 200mg/dl and cardiac disorders will be excluded. 7. Subjects with congenital anomalies, localized infection, Inflammatory bowel disease with polyps will be excluded. 8. Malignancy cases of any organ will be excluded. 9. Pregnant women. 10. Hepatitis B, Tuberculosis, HIV & VDRL positive cases will be excluded. 11. Patients who are contra-indicated for pratisarana khara karma.(Su. Su.11/28)

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is to assess the efficacy of Karanja Kshara and Sclerotherapy in reducing the symptoms and severity of 2nd-degree hemorrhoids. This will be measured by the reduction in hemorrhoid severity score, which includes parameters such as pain, bleeding, and prolapse, using a standardized scoring system.Timepoint: Baseline, Day 15, Day 30—

Secondary

MeasureTime frame
1. VAS 2. Size of Hemorrhoid massTimepoint: Baseline, Day 15, Day 30—

Countries

India

Contacts

Public ContactDR DARSHANA RAMOLE

Shree Swaminarayan Ayurvedic college,Kalol.

drdarshna@swaminarayanuniversity.ac.in9970728218

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026